INmune Bio, Inc. (INMB) vs Microbot Medical Inc. (MBOT)
A side-by-side comparison of INmune Bio, Inc. and Microbot Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INMB
INmune Bio, Inc.
$1.91HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
MBOT
Microbot Medical Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
Total return — INMB vs MBOT
growth of $100 · dividends reinvested · last 8yINMB -75.7% (-16.2%/yr)MBOT -88.3% (-23.5%/yr)INMB compounded faster over this window
INMB MBOT
INMB vs MBOT: by the numbers
- •INMB is the larger company ($51M vs $49M market cap).
- •Both run net losses; MBOT's is the smaller (-4722.25% vs -91866.00% net margin).
Metrics side by side
Valuation
| Metric | INMB | MBOT |
|---|---|---|
| P/S ratio | N/A | 142.97 |
| P/B ratio | 2.49 | 0.72 |
Profitability
| Metric | INMB | MBOT |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -61738.00% | 0.00% |
| Net margin | -91866.00% | -4722.25% |
| ROE | -90.44% | -23.70% |
| ROIC | -96.37% | -26.51% |
Growth (annualized)
| Metric | INMB | MBOT |
|---|---|---|
| Total return CAGR (5Y) | -36.88% | -31.63% |
Frequently asked
- How have INMB and MBOT total returns compared?
- Over the past 5 years, INMB delivered -36.88% and MBOT delivered -31.63% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.